Priority Symptoms in Advanced Breast Cancer: Development and Initial Validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16)-Reference-Cited by-同舟云学术

Priority Symptoms in Advanced Breast Cancer: Development and Initial Validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16)

Published:2012-01 Issue:1 Volume:15 Page:183-190
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Garcia Sofia F.,Rosenbloom Sarah K.,Beaumont Jennifer L.,Merkel Douglas,Von Roenn Jamie H.,Rao Deepa,Cella David

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference40 articles.

1. Cancer Facts & Figures 2010,2010

2. Global Cancer Facts & Figures;Garcia,2007

3. Quality of life in breast cancer---results from 3 cancer research campaign studies;Fallowfield;Acta Clin Belg,1993

4. Psychosocial impact of breast cancer: a critical review;Glanz;Ann Behav Med,1992

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validity, reliability, responsiveness, and clinically meaningful change threshold estimates of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16);Journal of Patient-Reported Outcomes;2024-08-15

2. Symptom network and quality of life of breast cancer patients receiving multimodal cancer treatment: Cross-sectional study;European Journal of Oncology Nursing;2024-08

3. Adjuvant platinum versus capecitabine for residual, invasive, triple‐negative breast cancer: Patient‐reported outcomes in ECOG‐ACRIN EA1131;Cancer;2024-01-18

4. Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer;JAMA Oncology;2023-10-01

5. Understanding the patient experience and treatment benefits in patients with non–small‐cell lung cancer with brain metastasis;Cancer Medicine;2023-06